Precision Medicine
In some cases, more data is needed to draw conclusions, and in others, the tech just isn’t there yet, John Quackenbush, a computational biologist at Harvard's Dana Farber Cancer Institute, says.
Prestigious prize highlights promising new direction in brain cancer research at Weill Cornell Medicine and NewYork-Presbyterian.
Two centers will share a $2 million National Cancer Institute grant to study cancer health disparities.
Allowing patients to become partners with practitioners in their care is where an effective wellness plan and prevention starts.
The legendary singer claims Soon-Shiong and other Altor board members hid the success of a promising cancer and AIDS/HIV drug.
21st Century Cures Act is helping drive expansion in the cellular therapies, with the field valued at $25 billion.
A new website from National Human Genome Research Institute aims to help RNs integrate genomics into their patient care.
Oregon Health & Science University will run analytics against clinical data to deliver decision support to clinicians.
The organizations will build a repository for precision and personalized medicine that they hope new startups will use to innovate.
The startup has the only FDA authorization for direct-to-consumer genetic tests.